DB
CFMS

Dmitry Balyasny’s Conformis, Inc. Common Stock CFMS Stock Holding History

Dmitry Balyasny’s Portfolio CFMS Stock Details CFMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-676
Closed -$40K – 2430
2017
Q4 		$40K Buy
+676
New +$54K ﹤0.01% 2019

Other funds holding CFMS

ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CPH
C Partners Holding Zurich, Switzerland $330M AUM 11.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Dmitry Balyasny's CFMS Position: Q1 2018 in Review

Dmitry Balyasny sold out of Conformis, Inc. Common Stock (CFMS) in Q1 2018, closing a stake of 676 shares — an estimated $40K sold.

Dmitry Balyasny first reported a position in CFMS in Q4 2017 and held it in 1 quarter. The position peaked at $40K in Q4 2017. 79 funds tracked by Wall St. Rank hold CFMS as of Q1 2018.

  • Dmitry Balyasny reported no remaining Conformis, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Dmitry Balyasny sold 676 Conformis, Inc. Common Stock shares in Q1 2018, an estimated $40K.
  • Dmitry Balyasny first reported a position in Conformis, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Dmitry Balyasny's Conformis, Inc. Common Stock position peaked at $40K in Q4 2017.
  • 79 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q1 2018.

Based on Balyasny Asset Management's 13F filing for Q1 2018, filed 15 May 2018.